Compounds > nonyl-4-hydroxyquinoline-n-oxide
Page last updated: 2024-09-03

nonyl-4-hydroxyquinoline-n-oxide and quinidine

nonyl-4-hydroxyquinoline-n-oxide has been researched along with quinidine in 1 studies

Compound Research Comparison

Studies
(nonyl-4-hydroxyquinoline-n-oxide)		Trials
(nonyl-4-hydroxyquinoline-n-oxide)		Recent Studies (post-2010)
(nonyl-4-hydroxyquinoline-n-oxide)		Studies
(quinidine)		Trials
(quinidine)		Recent Studies (post-2010) (quinidine)
27076,608387594

Protein Interaction Comparison

ProteinTaxonomynonyl-4-hydroxyquinoline-n-oxide (IC50)quinidine (IC50)
Voltage-dependent L-type calcium channel subunit alpha-1FHomo sapiens (human)6.4
CholinesteraseHomo sapiens (human)1.23
ATP-dependent translocase ABCB1Mus musculus (house mouse)10
ATP-dependent translocase ABCB1Homo sapiens (human)3.32
Cytochrome P450 2D26Rattus norvegicus (Norway rat)2.8
Cytochrome P450 2D6Homo sapiens (human)0.3532
Potassium voltage-gated channel subfamily A member 5Homo sapiens (human)7.3
CholinesteraseEquus caballus (horse)7.37
Voltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)6.4
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)0.7882
Voltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)6.4
Voltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)6.4
Sodium channel protein type 5 subunit alphaHomo sapiens (human)6.9
Potassium voltage-gated channel subfamily D member 2Rattus norvegicus (Norway rat)2.2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Handzlik, J; Jastrzębska-Więsek, M; Kieć-Kononowicz, K; Kucwaj-Brysz, K; Latacz, G; Lubelska, A; Partyka, A; Wesołowska, A1

Other Studies

1 other study(ies) available for nonyl-4-hydroxyquinoline-n-oxide and quinidine

ArticleYear
MF-8, a novel promising arylpiperazine-hydantoin based 5-HT
    Bioorganic & medicinal chemistry letters, 2018, 03-01, Volume: 28, Issue:5

    Topics: Dose-Response Relationship, Drug; Humans; Hydantoins; Molecular Structure; Piperazines; Receptors, Serotonin; Serotonin Antagonists; Structure-Activity Relationship

2018